
    
      The aim is to investigate whether n-3 PUFA's can be used to prevent postprandial hypoglycemia
      and its unfavorable consequences, such as stimulation of cortisol and adrenal androgen
      secretion, in women with polycystic ovarian syndrome.
    
  